Following two cycles of chemotherapy consisting of bleomycin (15 mg for three consecutive days), etoposide (150 mg for four consecutive days) and cisplatin (40 mg for three consecutive days; termed a BEP regimen), the serum AFP levels decreased to 1,251.27 ng/ml on January 7, 2010 and the CT scan revealed that the tumor size had significantly reduced (Fig. 2). This evidence concerns the gene AFP and neoplasm.